Pub. L. 117-328, div. FF, tit. I, subtit. B, ch. 5, sec. 1252

CHANGES TO FEDERAL OPIOID TREATMENT STANDARDS.

EnactedYear: 2022Length: 207 wordsOfficial source
SEC. 1252. CHANGES TO FEDERAL OPIOID TREATMENT STANDARDS.(a) Mobile Medication Units.—Section 302(e) of the Controlled Substances Act (21 U.S.C. 822(e)) is amended by adding at the end the following:“(3) Notwithstanding paragraph (1), a registrant that is dispensing pursuant to section 303(g) narcotic drugs to individuals for maintenance treatment or detoxification treatment shall not be required to have a separate registration to incorporate one or more mobile medication units into the registrant’s practice to dispense such narcotics at locations other than the registrant’s principal place of business or professional practice described in paragraph (1), so long as the registrant meets such standards for operation of a mobile medication unit as the Attorney General may establish.” . (b) Revise Opioid Treatment Program Admission Criteria to Eliminate Requirement That Patients Have an Opioid Use Disorder for at Least 1 Year.—Not later than 18 months after the date of enactment of this Act, the Secretary of Health and Human Services shall revise section 8.12(e)(1) of title 42, Code of Federal Regulations (or successor regulations), to eliminate the requirement that an opioid treatment program only admit an individual for treatment under the program if the individual has been addicted to opioids for at least 1 year before being so admitted for treatment.
Pub. L. 117-328, div. FF, tit. I, subtit. B, ch. 5, sec. 1252: CHANGES TO FEDERAL OPIOID TREATMENT STANDARDS. | Justis AI